Padella A.; Fontana M.C.; Marconi G.; Fonzi E.; Petracci E.; Ferrari A.; Baldazzi C.; Papayannidis C.; Ghelli Luserna Di Rora A.; Testoni N.; Castellani G.; Haferlach T.; Martinelli G.; Simonetti G., Loss of PALB2 predicts poor prognosis in acute myeloid leukemia and suggests novel therapeutic strategies targeting the DNA repair pathway, «BLOOD CANCER JOURNAL», 2021, 11, Article number: 7 , pp. 7 - 28 [Scientific article]Open Access
Yee, Karen; Papayannidis, Cristina; Vey, Norbert; Dickinson, Michael J.; Kelly, Kevin R.; Assouline, Sarit; Kasner, Margaret; Seiter, Karen; Drummond, Mark W.; Yoon, Sung-Soo; Lee, Je-Hwan; Blotner, Steven; Jukofsky, Lori; Pierceall, William E.; Zhi, Jianguo; Simon, Silke; Higgins, Brian; Nichols, Gwen; Monnet, Annabelle; Muehlbauer, Susanne; Ott, Marion; Chen, Lin-Chi; Martinelli, Giovanni, Murine double minute 2 inhibition alone or with cytarabine in acute myeloid leukemia: Results from an idasanutlin phase 1/1b study⋆, «LEUKEMIA RESEARCH», 2021, 100, Article number: 106489 , pp. 1 - 9 [Scientific article]
Soverini, S.; Martelli, M.; Bavaro, L.; De Benedittis, C.; Papayannidis, C.; Sartor, C.; Sora, F.; Albano, F.; Galimberti, S.; Abruzzese, E.; Annunziata, M.; Russo, S.; Stulle, M.; Imovilli, A.; Bonifacio, M.; Maino, E.; Stagno, F.; Maria Basilico, C.; Borlenghi, E.; Fozza, C.; Mignone, F.; Minari, R.; Stella, S.; Baccarani, M.; Cavo, M.; Martinelli, G., Next-generation sequencing improves BCR-ABL1 mutation detection in Philadelphia chromosome-positive acute lymphoblastic leukaemia, «BRITISH JOURNAL OF HAEMATOLOGY», 2021, 193, pp. 271 - 279 [Scientific article]
Fontana, Maria Chiara; Nanni, Jacopo; Ghelli Luserna di Rorà, Andrea; Petracci, Elisabetta; Padella, Antonella; Ghetti, Martina; Ferrari, Anna; Marconi, Giovanni; Soverini, Simona; Iacobucci, Ilaria; Papayannidis, Cristina; Curti, Antonio; Audisio, Ernesta; Giannini, Maria Benedetta; Rondoni, Michela; Lanza, Francesco; Cavo, Michele; Martinelli, Giovanni; Simonetti, Giorgia, Pharmacological Inhibition of WIP1 Sensitizes Acute Myeloid Leukemia Cells to the MDM2 Inhibitor Nutlin-3a, «BIOMEDICINES», 2021, 9, pp. 1 - 19 [Scientific article]
Fontana M.C.; Nanni J.; Di Rora A.G.L.; Petracci E.; Padella A.; Ghetti M.; Ferrari A.; Marconi G.; Soverini S.; Iacobucci I.; Papayannidis C.; Curti A.; Audisio E.; Giannini M.B.; Rondoni M.; Lanza F.; Cavo M.; Martinelli G.; Simonetti G., Pharmacological inhibition of wip1 sensitizes acute myeloid leukemia cells to the mdm2 inhibitor nutlin-3a, «BIOMEDICINES», 2021, 9, pp. 388 - 388 [Scientific article]Open Access
Bonifacio, Massimiliano; Papayannidis, Cristina; Lussana, Federico; Fracchiolla, Nicola; Annunziata, Mario; Sica, Simona; Delia, Mario; Foà, Robin; Pizzolo, Giovanni; Chiaretti, Sabina, Real-World Multicenter Experience in Tumor Debulking Prior to Blinatumomab Administration in Adult Patients With Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia, «FRONTIERS IN ONCOLOGY», 2021, 11, Article number: 804714 , pp. 1 - 7 [Scientific article]
Ferrari, Anna; Ghelli Luserna Di Rora, Andrea; Domizio, Chiara; Papayannidis, Cristina; Simonetti, Giorgia; Maria Hernández‐Rivas, Jesus; Rondoni, Michela; Giglio, Fabio; Abruzzese, Elisabetta; Imovilli, Annalisa; Iacobucci, Ilaria; Calistri, Daniele; Martinelli, Giovanni, Rearrangements of ATP5L‐KMT2A in acute lymphoblastic leukaemia, «BRITISH JOURNAL OF HAEMATOLOGY», 2021, 192, pp. 139 - 144 [Scientific article]
Marconi G.; De Polo S.; Martinelli G.; Nanni J.; Bertamini L.; Talami A.; Olivi M.; Ragaini S.; Abbenante M.C.; Sartor C.; Ottaviani E.; Bochicchio M.T.; Parisi S.; Fontana M.C.; Cristiano G.; Raffini M.; Baldazzi C.; Testoni N.; Bonifazi F.; Paolini S.; Curti A.; Cavo M.; Papayannidis C., Safety profile and impact on survival of tyrosine kinase inhibitors versus conventional therapy in relapse or refractory FLT3 positive acute myeloid leukemia patients, «LEUKEMIA RESEARCH», 2021, 101, Article number: 106497 , pp. 1 - 7 [Scientific article]
Jamieson, Catriona; Martinelli, Giovanni; Papayannidis, Cristina; Cortes, Jorge E., Hedgehog Pathway Inhibitors: A New Therapeutic Class for the Treatment of Acute Myeloid Leukemia, «BLOOD CANCER DISCOVERY», 2020, 1, pp. 134 - 145 [Scientific article]
Konopleva, Marina; Martinelli, Giovanni; Daver, Naval; Papayannidis, Cristina; Wei, Andrew; Higgins, Brian; Ott, Marion; Mascarenhas, John; Andreeff, Michael, MDM2 inhibition: an important step forward in cancer therapy, «LEUKEMIA», 2020, 34, pp. 2858 - 2874 [Scientific article]
Marconi G.; Talami A.; Abbenante M.C.; Sartor C.; Parisi S.; Nanni J.; Bertamini L.; Ragaini S.; Olivi M.; de Polo S.; Cristiano G.; Fontana M.C.; Bochicchio M.T.; Ottaviani E.; Arpinati M.; Sessa M.; Baldazzi C.; Caso L.; Testoni N.; Baccarani M.; Bonifazi F.; Martinelli G.; Paolini S.; Cavo M.; Papayannidis C.; Curti A., MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia, «EUROPEAN JOURNAL OF HAEMATOLOGY», 2020, 105, pp. 47 - 55 [Scientific article]
Montesinos, Pau; Beckermann, Benjamin M; Catalani, Olivier; Esteve, Jordi; Gamel, Katia; Konopleva, Marina Y; Martinelli, Giovanni; Monnet, Annabelle; Papayannidis, Cristina; Park, Aaron; Récher, Christian; Rodríguez-Veiga, Rebeca; Röllig, Christoph; Vey, Norbert; Wei, Andrew H; Yoon, Sung-Soo; Fenaux, Pierre, MIRROS: A Randomized, Placebo-Controlled, Phase III Trial of Cytarabine ± Idasanutlin in Relapsed or Refractory Acute Myeloid Leukemia, «FUTURE ONCOLOGY», 2020, 16, pp. 807 - 815 [Scientific article]
Candoni A.; Lazzarotto D.; Ferrara F.; Curti A.; Lussana F.; Papayannidis C.; Del Principe M.I.; Bonifacio M.; Mosna F.; Delia M.; Minetto P.; Gottardi M.; Fracchiolla N.; Mancini V.; Forghieri F.; Zappasodi P.; Cerrano M.; Vitale A.; Audisio E.; Trappolini S.; Romani C.; Defina M.; Imbergamo S.; Ciccone N.; Santoro L.; Cambò B.; Iaccarino S.; Dargenio M.; Aprile L.; Chiaretti S.; Fanin R.; Pizzolo G.; Foà R., Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL study, «AMERICAN JOURNAL OF HEMATOLOGY», 2020, 95, pp. 1466 - 1472 [Scientific article]
Sabina Chiaretti, null; Monica Messina, null; Irene Della Starza, null; Alfonso Piciocchi, null; Luciana Cafforio, null; Marzia Cavalli, null; Akram Taherinasab, null; Michela Ansuinelli, null; Loredana Elia, null; Guglielmo Albertini Petroni, null; Roberta La Starza, null; Martina Canichella, null; Alessia Lauretti, null; Maria Ctristina Puzzolo, null; Valentina Pierini, null; Alessandra Santoro, null; Orietta Spinelli, null; Valerio Apicella, null; Saveria Capria, null; Francesco Di Raimondo, null; Paolo De Fabritiis, null; Cristina Papayannidis; Anna Candoni, null; Roberto Cairoli, null; Marco Cerrano, null; Nicola Fracchiolla, null; Daniele Mattei, null; Chiara Cattaneo, null; Antonella Vitale, null; Enrico Crea, null; Paola Fazi, null; Cristina Mecucci, null; Alessandro Rambaldi, null; Anna Guarini, null; Renato Bassan, null; Robin Foà, null, Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913, «HAEMATOLOGICA», 2020, 106, pp. 1559 - 1568 [Scientific article]
Montesinos, Pau; Roboz, Gail J.; Bulabois, Claude-Eric; Subklewe, Marion; Platzbecker, Uwe; Ofran, Yishai; Papayannidis, Cristina; Wierzbowska, Agnieszka; Shin, Ho Jin; Doronin, Vadim; Deneberg, Stefan; Yeh, Su-Peng; Ozcan, Mehmet Ali; Knapper, Steven; Cortes, Jorge; Pollyea, Daniel A.; Ossenkoppele, Gert; Giralt, Sergio; Döhner, Hartmut; Heuser, Michael; Xiu, Liang; Singh, Indrajeet; Huang, Fei; Larsen, Julie S.; Wei, Andrew H., Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter, randomized, phase 2/3 study, «LEUKEMIA», 2020, 35, pp. 62 - 74 [Scientific article]
